VIGL - Financial Reports List - Vigil Neuroscience, Inc. - IntrinsicAlpha

Vigil Neuroscience, Inc. VIGL

Healthcare - Biotechnology - NASDAQ - US

$ 1.79

-1.75 %

$ 83.5 M

Market Cap

-0.81

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-7.47%	-5.27%
Annual Report	FY	10-K	2024-12-31	0.00%	-1.96%	-0.92%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	6.04%	7.37%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-5.22%	-2.58%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-6.35%	-3.08%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-154.68%	-26.41%
Annual Report	FY	10-K	2023-12-31	0.00%	-22.02%	-29.01%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-18.04%	-26.56%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-18.75%	-28.58%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-22.26%	-35.50%

1